Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of LY333531 on Albuminuria in Patients With Type 2 Diabetes A Pilot Clinical Trial

NCT00044148 is registered in ClinicalTrials.gov with Chromaderm, Inc. as lead sponsor.

NCT NCT00044148
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00044148 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of LY333531 on Albuminuria in Patients With Type 2 Diabetes A Pilot Clinical Trial
Lead sponsor
Chromaderm, Inc.
Phase
Phase 2
Overall status
Completed
Start date
July 16, 2002
Completion date
April 28, 2004
Enrollment
Not reported
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic nephropathy